Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial.

已完结 20 由哒哒发布于 2026/3/12 10:05:55

DOI:10.4244/EIJ-D-18-01000
作者：Michael Haude,?Hüseyin Ince,?Ralph Toelg,?Pedro Alves Lemos,?Clemens von Birgelen,?Evald H?j Christiansen,?William Wijns,?Franz-Josef Neumann,?Eric Eeckhout,?Hector M Garcia-Garcia,?Ron Waksman
文献类型：期刊论文
补充材料：只需要正文

其它数据库

Abstract：Aims: We aimed to evaluate the safety and performance of a magnesium-based sirolimus-eluting metal scaffold at three-year follow-up to assess vessel response two years beyond scaffold resorp

应助信息

11小时前

哎嘿

202603121010586762863.pdf 已采纳

11小时前

Book学术机器人

2026/3/12 10:05:55 未找到该文献，机器人已退出，请等待人工下载

2026/3/12 10:05:55 Book学术AI机器人收到请求，开始寻找文献

2026/3/12 10:05:55 已向机器人发送请求

11小时前

哒哒发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Fluorene-based π-conjugated polymers for OLEDs: advances, opportunities, and challenges